FTC Updates Health Claims Substantiation Guidance
By Alvin J. Lorman, AAHP Legal Counsel In December 2022, the Federal Trade Commission released a lengthy guidance document on the substantiation it expects for health claims, Health Products Compliance…
Read MoreFDA Finalizes Homeopathic Guidance
By Alissa Gould, AAHP Communications Chair Seven years after the U.S. Food and Drug Administration (FDA) held a public hearing on homeopathic product regulation and two rounds of public comments,…
Read MoreFTC Proposes Making Rules Affecting Endorsements and Testimonials
By Alvin Lorman, AAHP Counsel Calling fake and deceptive product reviews and endorsements “problematic” and its remedial authority “limited,” the Federal Trade Commission (FTC) has taken the first step toward…
Read MoreIndustry Leader Spotlight: Sandra Chase, M.D.
By Eric Foxman, with thanks to Nick Nossaman, M.D., and the American Institute of Homeopathy for the basis of this profile. In reviewing Dr. Sandra Chase’s career in homeopathy, one…
Read MoreMid-Term Elections Usher in Divided Government in Washington
By Pete Evich, Vice President, Van Scoyoc Associates It wasn’t the national red wave many top Republicans predicted, but the GOP prevailed in enough races to gain control of the…
Read MoreHomeopathy: Increasing Access to Health Care
By Holly Manoogian, HWB Executive Director “Our partnership with Homeopaths Without Borders has opened up an opportunity for Wabanaki community members to access care that is comparable to traditional Wabanaki…
Read MoreSupporting Your Success — 2022 Accomplishments
Mark Land, AAHP President I think it is safe to say Americans remained tentative in many areas of everyday life in 2022. Things like travel, business conventions, and entertainment events…
Read MoreAAHP’s Work in Washington: A Retrospective Heading into Our Centennial
By Pete Evich, Vice President, Van Scoyoc Associates It was 12 years ago that the American Association of Homeopathic Pharmacists (AAHP) first embarked upon a federal relations program. While…
Read MoreAAHP Updates Rep. Curtis on Homeopathic Industry Issues
On Sept. 16, 2022, AAHP once again sat down with U.S. Congressman John Curtis (R-Utah-3rd district) to brief him on the homeopathic industry and AAHP’s current work with the U.S.…
Read MoreNewly Revised FDA Inspection Guidance Document
By Eric Foxman, AAHP Secretary, Pharm. (Ret.) The U.S. Food and Drug Administration released a revised Inspection Guidance for its staff. While the overall contents are not new, it is…
Read More